Luye Pharma Group Ltd.
LYPHF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $4,937,145 | $3,238,973 | $2,323,740 | $2,438,252 |
| Short-Term Investments | $1,566,067 | $1,271,695 | $3,220,524 | $3,072,057 |
| Receivables | $4,300,696 | $2,587,657 | $1,783,686 | $1,765,096 |
| Inventory | $911,893 | $827,863 | $772,939 | $746,344 |
| Other Curr. Assets | $1,592,306 | $1,181,327 | $2,684,924 | $2,374,915 |
| Total Curr. Assets | $13,308,107 | $10,703,282 | $10,785,813 | $10,396,664 |
| Property Plant & Equip (Net) | $5,890,856 | $5,088,505 | $4,909,126 | $4,594,470 |
| Goodwill | $1,012,456 | $1,041,930 | $1,003,371 | $985,413 |
| Intangibles | $6,585,487 | $4,804,781 | $5,984,684 | $5,441,833 |
| Long-Term Investments | $926,338 | $696,739 | -$2,106,440 | -$2,489,862 |
| Tax Assets | $163,578 | $1,271,695 | $113,947 | $133,106 |
| Other NC Assets | $1,725,378 | $3,155,478 | $3,559,124 | $3,520,437 |
| Total NC Assets | $16,304,093 | $14,787,433 | $13,463,812 | $12,185,397 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $29,612,200 | $25,490,715 | $24,249,625 | $22,582,061 |
| Liabilities | – | – | – | – |
| Payables | $689,300 | $767,187 | $559,944 | $570,890 |
| Short-Term Debt | $7,585,074 | $5,195,754 | $6,839,788 | $5,263,216 |
| Tax Payable | $434,680 | $294,891 | $256,323 | $205,072 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $2,060,088 | $1,879,975 | $1,831,148 | $1,291,015 |
| Total Curr. Liab. | $10,769,142 | $8,137,807 | $9,487,203 | $7,330,193 |
| LT Debt | $2,735,980 | $3,228,193 | $2,264,731 | $4,227,577 |
| Deferred Rev, NC | $118,207 | $0 | $174,965 | $209,387 |
| Deferred Tax Liab, NC | $36,479 | $0 | $56,034 | $57,874 |
| Other NC Liab. | $198,722 | $596,221 | $1,455,969 | $1,910,388 |
| Total NC Liab. | $3,089,388 | $3,824,414 | $3,720,700 | $6,137,965 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $61,955 | $70,646 | $38,491 | $41,950 |
| Total Liabilities | $13,858,530 | $11,962,221 | $13,207,903 | $13,468,158 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $486,107 | $486,107 | $456,953 | $455,835 |
| Retained Earnings | $0 | $7,380,544 | $6,667,268 | $6,061,829 |
| AOCI | $0 | $505,214 | $254,463 | $534,036 |
| Other Equity | $13,668,422 | $4,159,320 | $2,797,270 | $1,436,423 |
| Total Equity | $14,154,529 | $12,531,185 | $10,175,954 | $8,488,123 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $1,599,141 | $997,309 | $865,768 | $625,780 |
| Total Liab. & Tot. Equity | $29,612,200 | $25,490,715 | $24,249,625 | $22,582,061 |
| Net Debt | $5,383,909 | $5,184,974 | $6,780,779 | $7,052,541 |